(Stroke. 1996;27:2026-2032.)
© 1996 American Heart Association, Inc.
Articles |
the Departments of Radiology (J. van der G., W.P.Th.M.M.) and Vascular Surgery (B.C.E.), University Hospital Utrecht (Netherlands).
Correspondence to Dr J. van der Grond, Department of Radiology, University Hospital Utrecht, Heidelberglaan 100, 3584 CX Utrecht, Netherlands. E-mail j.vandergrond@rrn.azu.nl.
| Abstract |
|---|
|
|
|---|
Methods Fifty-six patients with unilateral severe stenosis of the ICA and 14 control subjects underwent MR imaging, 1H MR spectroscopy, and MR angiography. Anaerobic metabolic changes were studied by assessing N-acetyl aspartate/choline and lactate/N-acetyl aspartate ratios in the symptomatic and asymptomatic hemispheres. Quantitative flow was measured in the common carotid arteries (CCAs), the ICAs, the basilar artery, and the middle cerebral arteries (MCAs).
Results Blood flow was significantly decreased in the CCA, ICA, and MCA on the ipsilateral side compared with the contralateral side. Flow in the basilar artery was increased, whereas flow in the contralateral MCA was decreased compared with control subjects. We found a significant correlation between anaerobic metabolic changes and the reduction in blood flow in the CCA, ICA, and MCA on the ipsilateral side.
Conclusions This study shows that cerebral metabolism is less impaired in patients with relatively high flow in the major cerebral arteries on the ipsilateral side than in patients with relatively low flow on that side. The combination of MR spectroscopy and MR angiography can be of additional value in the understanding of cerebral hemodynamics and metabolism in patients with vascular disorders.
Key Words: carotid arteries cerebral blood flow cerebral ischemia magnetic resonance imaging
| Introduction |
|---|
|
|
|---|
The purpose of this study is to investigate whether the combination of blood flow measurements in the major cerebral arteries and measurements of cerebral metabolism can provide new insight into the hemodynamic effect of carotid lesions in patients with severe stenosis of the ICA.
| Subjects and Methods |
|---|
|
|
|---|
The control group consisted of 14 subjects (9 men, 5 women; age range, 49 to 81 years; mean±SD, 60.3±11.3 years). None of the control subjects had suffered a cerebral event, and MRI of the brain was normal in all of them (no white or gray matter signal abnormalities on T1- and T2-weighted MRI). On MRA all control subjects showed normal carotid bifurcations without any sign of atherosclerotic lesions in the CCAs, ICAs, and ECAs. Study protocols were approved by the Human Research Committee of our hospital.
MRI, MRS, and MRA
MRI, MRS, and MRA studies were performed on a Philips Gyroscan ACS-NT15 whole-body system operating at 1.5 T. For MRI we made 19 sagittal T1-weighted scout slices (slice thickness, 4 mm; 0.6-mm slice gap; TR, 545 ms; TE, 15 ms) and 15 transaxial T2-weighted slices (slice thickness, 7 mm; 1.5-mm slice gap; TR, 2000 ms; TE, 20 and 100 ms).
After MRI, the VOI for 1H MRS was chosen from the transaxial images. MRS was performed with a single-volume technique. In each subject two single VOIs were selected in the centrum semiovale: one in the symptomatic hemisphere and one in the asymptomatic hemisphere. The anterior-posterior and left-right dimensions of the VOI were chosen such that regions containing subcutaneous lipid were excluded and were typically 70 mm and 35 mm in anterior-posterior and left-right directions. In all subjects the caudal-cranial dimension of the VOI was 15 mm. All volumes were positioned at least 2 cm away from gray/white matter hyperintensities. If this was not possible, the dimensions of the VOI were changed. If infarcts were present on MRI, care was taken to maintain the 2-cm distance between lesions and the selected VOIs. In each MR examination the dimensions of the selected VOIs were kept equal in the symptomatic and asymptomatic hemispheres. All VOIs contained primarily white matter. After selection of a VOI, the 90° pulse length was determined. To minimize eddy currents and to maximize the water-echo signal, localized spectroscopy was first performed without water suppression for adjustment of the gradients ("gradient tuning"). This was followed by localized automatic shimming of the VOI, resulting typically in a water-resonance line width of 6 Hz (full width at half height) or less. Water suppression was performed by selective excitation (60-Hz bandwidth), followed by a spoiler gradient. A double spin-echo point-resolved spectroscopy sequence was used for VOI localization.27 28 Each measurement was performed with a TR of 2000 ms, a TE of 136 ms, 2048 time domain data points, 4000-Hz spectral width, and 64 averages. After zero-filling to 4096 data points, gaussian multiplication of 5 Hz, exponential multiplication of -4 Hz (line broadening), Fourier transformation, and linear baseline correction, total choline, total creatine, NAA (referenced at 2.01 ppm), and lactate peaks were identified by their chemical shifts.29 Since we were unable to calculate absolute metabolic concentrations, concentrations are expressed as the ratio between peak intensities (NAA/choline, NAA/creatine, and lactate/NAA ratios). To distinguish lactate resonances from lipid resonances at a TE of 136 ms, lactate was defined as an inverted resonance at 1.33 ppm with a signal-to-noise ratio larger than 2 and a clear identifiable 7-Hz J-coupling.
After MRI and MRS, quantitative flow measurements were performed in the CCAs, ICAs, basilar artery, and MCAs. All subjects underwent the same MRA protocol. First, two nontriggered two-dimensional phase-contrast MRA survey scans in coronal and sagittal orientations were performed to visualize the CCAs, carotid bifurcations, ICAs, ECAs, and the circle of Willis. In the sagittal orientation we used the following: 2 slices; slice thickness, 50 mm; -5 mm slice gap (overcontiguous slices); field of view, 250x250 mm; TR, 14 ms; TE, 7 ms; flip angle, 20°; velocity sensitivity, 30 cm/s; and 4 averages. In the coronal orientation we used a single slice (thickness, 60 mm) with the same parameters. Thereafter, two two-dimensional phase-contrast single slices for quantitative flow measurement were positioned. One slice was positioned perpendicular to both CCAs and the other slice perpendicular to the C3 segments of the ICAs and to the basilar artery (slice thickness, 5 mm; field of view, 250x250 mm; TR, 16 ms; TE, 9 ms; flip angle, 7.5°; velocity sensitivity, 100 cm/s; and 8 averages). Quantitative flow measurements were performed with previously optimized scan protocols featuring a radio-frequency spoiled gradient echo sequence with full echo sampling.30 These measurements were followed by a three-dimensional time-of-flight MRA measurement of the circle of Willis (50 slices; slice thickness, 0.6 mm; field of view, 100x100 mm; TR, 32 ms; TE, 7 ms; flip angle, 20°; and 2 averages). On the basis of the reconstruction of the circle of Willis in three directions, two two-dimensional phase-contrast single slices were positioned perpendicular to the left and right MCA (slice thickness, 5 mm; field of view, 250x250 mm; TR, 17 ms; TE, 10 ms; flip angle, 8°; velocity sensitivity, 70 cm/s; and 24 averages). The diameters of the anterior cerebral arteries and the posterior cerebral arteries were too small to perform reliable flow measurements. All volume flow data were obtained by integrating across manually drawn regions-of-interest that enclosed the vessel lumen as closely as possible. All images were evaluated by the same reader. Total patient time, including patient handling, was 35 minutes, from which approximately 15 to 20 minutes were used for MRA.
Statistical Analysis
For statistical analysis, repeated measures ANOVA was used to compare metabolic ratios by groups (four groups: symptomatic and asymptomatic hemispheres in patients and left and right hemispheres in control subjects, for a total of six comparisons). ANOVA by groups was also used to compare differences in blood flow of the CCAs, basilar artery, ICAs, and MCAs. Tests for linear correlation between metabolic ratios and blood flow were performed with bivariate Pearson correlation tests. Paired analysis of differences in metabolic ratios and differences in blood flow was performed using the Bonferroni t method (Dunn's multiple-comparison procedure [six comparisons]). All data are expressed as mean±SD. A value of P<.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
Table 2
shows the results of the flow measurements in the CCAs, ICAs, basilar artery, and MCAs. ANOVA showed that no flow asymmetries were present in the control group. Therefore, flow measurements of the left and right corresponding arteries in control subjects are grouped. This table shows that on the stenosed side flow is significantly reduced in the CCA, ICA, and MCA compared with the contralateral side and also compared with the control subjects. On the contralateral side flow was increased in the CCA compared with control subjects, whereas flow was decreased in the MCA compared with control subjects. Furthermore, flow in the basilar artery was significantly higher in patients than in control subjects.
|
Fig 3
shows the relationship between arterial flow in the ipsilateral CCA, ICA, and MCA with the ipsilateral NAA/choline and lactate/NAA ratios, respectively. Table 3
shows the corresponding correlation coefficient and significance. No significant correlation was found between flow in the basilar artery and the NAA/choline or lactate/NAA ratio. In addition, no significant correlation was found between flow and metabolic ratios on the asymptomatic side.
|
|
| Discussion |
|---|
|
|
|---|
MRA measurements showed that flow in the CCA, ICA, and MCA was decreased on the stenosed (symptomatic) side compared with the contralateral side. Similar MRA results for flow in the CCA and ICA have been described earlier.40 41 42 43 The mean values of flow in our study are comparable to these previous reports.40 41 42 43 However, since it is expected that cerebropetal flow is not only dependent on the actual grade of stenosis in the ICA but also on the presence of collateral pathways and the level of vasodilation,12 it is not useful to compare our data with these studies in detail. Blood flow in our control group was lower than that described by the group of Enzmann et al.44 This might be due to age effects, since it has been shown that cerebral blood flow is decreasing with age.45 The age range in our study was 49 to 81 years compared with 22 to 38 years in the study of Enzmann et al. More interesting in our study was the finding of increased flow in the basilar artery and decreased flow in both MCAs. The relatively small difference in flow between stenosed and contralateral MCA is likely to be caused by collateral circulation in the circle of Willis, by shunting blood from the asymptomatic side into the symptomatic side via the anterior communicating artery. Additionally, increased flow in the basilar artery was found. It is therefore likely that the symptomatic MCA is also provided by collateral flow via the posterior communicating artery, which is an important collateral pathway.46 However, the results from our study do not show whether increased flow in the basilar artery is a result of collateral flow via the posterior communicating artery or via leptomeningeal vessels. Flow in the ECA, which can be calculated from the difference in flow between the CCA and ICA, was lower on the stenosed side than on the contralateral side (133 mL/min versus 199 mL/min). The finding of decreased flow in the "symptomatic" ECA is surprising since it was expected that redistribution of blood flow (eg, via the ophthalmic artery) would cause an increased flow in the symptomatic ECA. We currently do not have a plausible explanation for this finding.
At present, in patients with severe lesions in the ICA, the effect of changes in ipsilateral arterial flow on the CBF is not clear.9 18 24 25 26 This study shows that when ipsilateral arterial blood flow is decreased, the NAA/choline ratio is decreased and the lactate/NAA ratio is increased in the ipsilateral hemisphere. Previous findings of decreased ipsilateral CBF in patients with severe stenosis of the ICA5 6 7 8 9 10 11 suggest that in some of these patients collateral flow is limited or has already reached a maximum capacity. According to the concept of compensatory response to reduced CPP, it is expected that a persisting decrease in CMRO2 (as measured with PET) leads to cerebral infarctions.36 Since we selected our VOI outside infarcted regions, the observed metabolite changes in this study probably occurred after CBF was decreased but before the CMRO2 was decreased. Compared with metabolic changes occurring in infarcted regions,31 32 33 34 35 the decreases in NAA/choline and lactate/NAA are relatively small. It is possible that, although the OEF is probably increased to maintain the CMRO2, small anaerobic changes already have taken place. The results of this study show that the CBF and cerebral metabolism are still coupled at this point. Further decrease in arterial flow will probably increase the OEF but also will increase anaerobic changes as measured with MRS. It should be noted that the metabolic parameters in this study are different from those used in PET studies. Therefore, anaerobic metabolic changes measured with MRS could be originating from other metabolic processes or from cell types other than those studied with PET. In this respect, it would be very interesting to match the results of MRS with the results of PET studies in the same patient population.
In conclusion, the results of this study show that in patients with severe stenosis of the ICA, the patients with relatively high flow in the major cerebral arteries on the ipsilateral side have less compromised cerebral metabolism than the patients with relatively low flow on that side. Therefore, the combination of MRS and MR flow measurements in the major cerebral arteries can be of additional value in the understanding of cerebral hemodynamics and metabolism in patients with vascular disorders. In particular, patients who have the combination of reduced ipsilateral arterial blood flow, low NAA/choline ratios, and increased lactate are probably at risk for infarction in the long term or if cerebral perfusion decreases further.36 47 48 49 Compared with SPECT, PET, and xenon techniques, MR measurements are faster, easier, and more available and hence more suitable for potential clinical applications.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received March 25, 1996; revision received July 29, 1996; accepted July 30, 1996.
| References |
|---|
|
|
|---|
2.
Simonson TM, Ryals TJ, Yuh WT, Farrar GP, Rezai K, Hoffman HT. MR imaging and HMPAO scintigraphy in conjunction with balloon test occlusion: value in predicting sequelae after permanent carotid occlusion. AJR Am J Roentgenol. 1992;159:1063-1068.
3. Guckel F, Brix G, Rempp K, Deimling M, Rother J, Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient-echo imaging. J Comput Assist Tomogr. 1994;18:344-351.[Medline] [Order article via Infotrieve]
4.
Nighoghossian N, Berthezene Y, Philippon B, Adeleine P, Froment JC, Trouillas MD. Hemodynamic parameter assessment with dynamic susceptibility contrast magnetic resonance imaging in unilateral symptomatic internal carotid artery occlusion. Stroke. 1996;27:474-479.
5.
Hayashida K, Hirose Y, Kaminaga T, Ishida Y, Imakita S, Takamiya M, Yokota I, Nishimura T. Detection of postural cerebral hypoperfusion with technetium-99 m-HMPAO brain SPECT in patients with cerebrovascular disease. J Nucl Med. 1993;34:1931-1935.
6. Rosenkranz K, Hierholzer J, Langer R, Hepp W, Palenker J, Felix R. Acetazolamide stimulation test in patients with unilateral internal carotid artery obstructions using transcranial Doppler and 99 mTc-HM-PAO-SPECT. Neurol Res. 1992;14:135-138.[Medline] [Order article via Infotrieve]
7. Cikrit DF, Burt RW, Dalsing MC, Lalka SG, Sawchuk AP, Waymire B, Witt RM. Acetazolamide enhanced single photon emission computed tomography (SPECT) evaluation of cerebral perfusion before and after carotid endarterectomy. J Vasc Surg. 1992;15:747-753.[Medline] [Order article via Infotrieve]
8. Sacca A, Pedrini L, Vitacchiano G, Pisano E, Zagni P, Bellanova B, Dondi M, Monetti N. Cerebral SPECT with 99 mTc-HMPAO in extracranial carotid pathology: evaluation of changes in the ischemic area after carotid endarterectomy. Int Angiol. 1992;11:117-121.[Medline] [Order article via Infotrieve]
9. Bishop CCP, Butler L, Hunt T, Burnand KG, Browse NL. Effect of carotid endarterectomy on cerebral blood flow and its response to hypercapnia. Br J Surg. 1987;74:994-996.[Medline] [Order article via Infotrieve]
10.
Burt RW, Witt RM, Cirkit DF, Reddy RV. Carotid artery disease: evaluation with acetazolamide-enhanced with Tc-99m HMPAO SPECT. Radiology. 1992;182:461-464.
11. Algotsson L, Ryding E, Rehncrona S, Messeter K. Cerebral blood flow during carotid endarterectomy determined by three dimensional SPECT measurement: relation to preoperative risk assessment. Eur J Vasc Surg. 1993;7:46-53.[Medline] [Order article via Infotrieve]
12. Powers WJ. Cerebral hemodynamics in ischemic cerebrovascular disease. Ann Neurol. 1991;29:231-240.[Medline] [Order article via Infotrieve]
13. Asenbaum S, Reinprecht A, Brucke T, Wenge S, Podreka I, Deecke L. A study of acetazolamide-induced changes in cerebral blood flow using 99 mTc HMPAO SPECT in patients with cerebrovascular disease. Neuroradiology. 1995;37:13-19.[Medline] [Order article via Infotrieve]
14. Piepgras A, Leinsinger G, Kirsch CM, Schmiedek P. STA-MCA bypass in bilateral carotid artery occlusion: clinical results and long-term effect on cerebrovascular reserve capacity. Neurol Res. 1994;16:104-107.[Medline] [Order article via Infotrieve]
15. Hirano T, Minematsu K, Hasegawa Y, Tanaka Y, Hayashida K, Yamaguchi T. Acetazolamide reactivity on 123I-IMP SPECT in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metab. 1994;14:763-770.[Medline] [Order article via Infotrieve]
16. Algotsson L, Ryding E, Rehncrona S, Messeter K. Cerebral blood flow during carotid endarterectomy determined by three dimensional SPECT measurement: relation to preoperative risk assessment. Eur J Vasc Surg. 1993;7:46-53.
17. Lord RS, Reid CV, Ramsay SC, Yeates MG. Unilateral carotid stenosis and impaired cerebral hemisphere vascular reserve. Ann Vasc Surg. 1992;6:438-442.[Medline] [Order article via Infotrieve]
18. Kawamura S, Sayama I, Yasui N, Uemura K. Haemodynamic and metabolic changes following extra-intracranial bypass surgery. Acta Neurochir (Wien).. 1994;126:135-139.[Medline] [Order article via Infotrieve]
19. Muraishi K, Kameyama M, Sato K, Sirane R, Ogawa A, Yashimoto T, Hatazawa J, Itoh M. Cerebral circulatory and metabolic changes following EC/IC bypass surgery in cerebral occlusive diseases. Neurol Res. 1993;15:97-103.[Medline] [Order article via Infotrieve]
20.
Van der Grond J, Balm R, Kappelle LJ, Eikelboom BC, Mali WPTM. Cerebral metabolism of patients with stenosis or occlusion of the internal carotid artery: A 1H-MR spectroscopic imaging study. Stroke. 1995;26:822-828.
21. Van der Grond J, Balm R, Klijn CJM, Kappelle LJ, Eikelboom BC, Mali WPTM. Cerebral metabolism of patients with stenosis of the internal carotid artery before and after endarterectomy. J Cereb Blood Flow Metab. 1996;16:320-326.[Medline] [Order article via Infotrieve]
22. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol.. 1990;11:431-439.[Abstract]
23. Challa VR, Bell MA, Moody DM. A combined H & E, alkaline phosphatase and high resolution microradiographic study of lacunes. Clin Neuropathol (Berl).. 1990;9:196-204.
24.
Sugimori H, Ibayashi S, Fujii K, Sadoshima S, Kuwabara Y, Fujishima M. Can transcranial Doppler really detect deduced cerebral perfusion states? Stroke. 1995;26:2053-2060.
25.
Maurer AH, Siegel JA, Comerota AJ, Morgan WA, Johnson MH. SPECT quantification of cerebral ischemia before and after carotid endarterectomy. J Nucl Med. 1990;31:1412-1420.
26.
Boysen G, Ladegaard-Pedersen HJ, Valentin N, Engell HC. Cerebral blood flow and internal carotid artery flow during carotid surgery. Stroke. 1970;1:253-260.
27. Ordidge RJ, Bendall MR, Gordon RE, Connelly A. Volume selection in vivo spectroscopy. In: Govil G, Khetrapal C, Saran A, eds. Magnetic Resonance in Biology and Medicine. New Delhi, India: Tata McGraw-Hill; 1985:387-397.
28. Bottomly PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1986;508:333-348.[Medline] [Order article via Infotrieve]
29. Michaelis T, Merboldt KD, Haenicke W, Gyngell ML, Bruhn H, Frahm J. On the identification of cerebral metabolites in localized 1H NMR spectra of human brain in vivo. NMR Biomed. 1991;4:90-98.[Medline] [Order article via Infotrieve]
30. Bakker CJG, Kouwenhoven M, Hartkamp MJ, Hoogeveen RM, Mali WPTM. Accuracy and precision of time-averaged flow as measured by nontriggered 2D phase-contrast MR angiography: a phantom evaluation. Magn Reson Imaging.. 1995;13:959-965.[Medline] [Order article via Infotrieve]
31.
Houkin K, Kamada K, Kamiyama H, Iwasaki Y, Abe H, Kashiwaba T. Longitudinal changes in proton magnetic resonance spectroscopy in cerebral infarction. Stroke. 1993;24:1316-1321.
32.
Graham GD, Blamire AM, Howseman AM, Rothman DL, Fayad PB, Brass LM, Petroff OAC, Shulman RG, Prichard JW. Proton magnetic resonance spectroscopy of cerebral lactate and other metabolites in stroke patients. Stroke. 1992;23:333-340.
33. Gideon P, Sperling B, Arlien-Søborg P, Olsen TS, Henriksen O. Long-term follow-up of cerebral infarction patients with proton magnetic resonance spectroscopy. Stroke. 1994;25:967-973.[Abstract]
34.
Felber SR, Aichner FT, Sauter R, Gerstenbrand F. Combined magnetic resonance imaging and proton MR spectroscopy of patients with acute stroke. Stroke. 1992;23:1106-1110.
35.
Barker PB, Gillard JH, van Zijl PCM, Soher BJ, Hanley DF, Agildere AM, Oppenheimer SM, Bryan RN. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology. 1994;192:723-732.
36.
Garcia JH, Lassen NA, Weiller C, Sperling BS, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 1996;27:761-765.
37.
Tallan HH. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem. 1957;224:41-45.
38. Birken DL, Oldendorf WH. N-Acetyl-L-aspartic acid: a literature review of a compound prominent in 1H - NMR spectroscopic studies of brain. Neurosci Neurobehav Rev. 1989;13:23-31.[Medline] [Order article via Infotrieve]
39. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981-989.[Abstract]
40.
Vanninen R, Koivisto K, Tulla H, Manninen H, Partanen K. Hemodynamic effects of carotid endarterectomy by magnetic resonance flow quantification. Stroke. 1995;26:84-89.
41. Davis WL, Turski PA, Gorbatenko KG, Weber D. Correlation of cine MR velocity measurement in the internal carotid artery with collateral flow in the circle of Willis. J Magn Reson Imaging.. 1993;3:603-609.[Medline] [Order article via Infotrieve]
42. Levine RL, Turski PA, Holmes KA, Grist TM. Comparison of magnetic resonance volume flow rates, angiography, and carotid Dopplers: preliminary results. Stroke. 1994;25:413-417.[Abstract]
43. Gordon IL, Stemmer EA, Wilson SE. Redistribution of blood flow after carotid endarterectomy. J Vasc Surg. 1995;22:349-360.[Medline] [Order article via Infotrieve]
44. Enzmann DR, Ross MR, Marks MP, Pelc NJ. Blood flow in major cerebral arteries measured by phase contrast cine MR. AJNR Am J Neuroradiol. 1994;15:123-129.[Abstract]
45.
Remmp KA, Brix G, Wenz F, Becker CR, Gueckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast enhanced MR imaging. Radiology. 1994;193:637-641.
46.
Schomer DF, Marks MP, Steinberg GK, Johnstone IM, Boothroyd DB, Ross MR, Pelc NJ, Enzmann DR. The anatomy of the posterior communicating artery as a risk factor for ischemic cerebral infarction. N Engl J Med. 1994;330:1565-1570.
47. Rehncrona S, Rosen I, Siesjo BK. Brain lactic acidosis and ischemic cell damage, I: biochemistry and neurophysiology. J Cereb Blood Flow Metab. 1981;1:297-311.[Medline] [Order article via Infotrieve]
48. Kalimo H, Rehncrona S, Soderfeldt B, Olsson Y, Siesjo BK. Brain lactic acidosis and ischemic cell damage, II: histopathology. J Cereb Blood Flow Metab. 1981;1:313-327.[Medline] [Order article via Infotrieve]
49.
Plum F. What causes infarction in ischemic brain? The Robert Wartenberg lecture. Neurology. 1983;33:222-233.
This article has been cited by other articles:
![]() |
M. Kamouchi, K. Kishikawa, Y. Okada, T. Inoue, S. Ibayashi, and M. Iida Reappraisal of Flow Velocity Ratio in Common Carotid Artery to Predict Hemodynamic Change in Carotid Stenosis AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kamouchi, K. Kishikawa, Y. Okada, T. Inoue, S. Ibayashi, and M. Iida Poststenotic Flow and Intracranial Hemodynamics in Patients with Carotid Stenosis: Transoral Carotid Ultrasonography Study AJNR Am. J. Neuroradiol., January 1, 2005; 26(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Bakker, C. J.M. Klijn, J. van der Grond, L. J. Kappelle, and A. Jennekens-Schinkel Cognition and quality of life in patients with carotid artery occlusion: A follow-up study Neurology, June 22, 2004; 62(12): 2230 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Lythgoe, A Simmons, A Pereira, M Cullinane, S Williams, and H S Markus Magnetic resonance markers of ischaemia: their correlation with vasodilatory reserve in patients with carotid artery stenosis and occlusion J. Neurol. Neurosurg. Psychiatry, July 1, 2001; 71(1): 58 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
K J van Everdingen, L J Kappelle, C J M Klijn, W P T M Mali, and J van der Grond Clinical features associated with internal carotid artery occlusion do not correlate with MRA cerebropetal flow measurements J. Neurol. Neurosurg. Psychiatry, March 1, 2001; 70(3): 333 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Rothwell and C. P. Warlow Low Risk of Ischemic Stroke in Patients With Reduced Internal Carotid Artery Lumen Diameter Distal to Severe Symptomatic Carotid Stenosis : Cerebral Protection Due to Low Poststenotic Flow? Stroke, March 1, 2000; 31(3): 622 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. M. Klijn, L. J. Kappelle, C. A. F. Tulleken, and J. van Gijn Symptomatic Carotid Artery Occlusion : A Reappraisal of Hemodynamic Factors Stroke, October 1, 1997; 28(10): 2084 - 2093. [Abstract] [Full Text] |
||||
![]() |
K. J. van Everdingen, C. J. M. Klijn, L. J. Kappelle, W. P. T. M. Mali, and J. van der Grond MRA Flow Quantification in Patients With a Symptomatic Internal Carotid Artery Occlusion Stroke, August 1, 1997; 28(8): 1595 - 1600. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |